|
Re: Financial Statement Q2, 2023 /MD&A
|
7
|
Resverlogix Corp.
|
Aug 12, 2023 05:50PM
|
|
Re: Did DM show some cards?
|
7
|
Resverlogix Corp.
|
Sep 07, 2020 01:09AM
|
|
Re: Interim Financial .... Interim MD&A .... Reporting
|
7
|
Zenith Epigenetics
|
Apr 07, 2024 11:51PM
|
|
Ya never know
|
7
|
Resverlogix Corp.
|
Apr 10, 2020 09:59PM
|
|
Who takes RVX-208 to market
|
7
|
Resverlogix Corp.
|
Jan 07, 2018 05:34PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
7
|
Resverlogix Corp.
|
May 14, 2022 07:16PM
|
|
BETonMACE top line data
|
7
|
Resverlogix Corp.
|
Jan 16, 2018 12:03AM
|
|
Re: A Question for all here, the frustrated people, the P.O people, the content people & the koolaid people.....
|
7
|
Resverlogix Corp.
|
Jan 08, 2021 06:23PM
|
|
Progress
|
7
|
Resverlogix Corp.
|
Jul 24, 2020 04:29PM
|
|
Re: AGM attendance
|
7
|
Resverlogix Corp.
|
May 23, 2022 12:38AM
|
|
Re: BETonMACE USA vs. non-USA brainstorming
|
7
|
Resverlogix Corp.
|
Nov 20, 2017 07:11PM
|
|
Re: New Share Price Contest update to Oct 12th
|
7
|
Resverlogix Corp.
|
Oct 14, 2019 02:35PM
|
|
Re: ... AGM thoughts...
|
7
|
Resverlogix Corp.
|
Nov 28, 2017 03:38PM
|
|
Re: RVX Market Value
|
7
|
Resverlogix Corp.
|
Jan 28, 2021 07:34PM
|
|
Re: The problem...as I see it
|
7
|
Resverlogix Corp.
|
Oct 20, 2020 01:19PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
6
|
Resverlogix Corp.
|
Apr 15, 2021 04:40PM
|
|
2024 Special Annual Meeting
|
6
|
Resverlogix Corp.
|
Jun 30, 2024 08:57PM
|
|
DSMB Charter
|
6
|
Resverlogix Corp.
|
Aug 11, 2016 02:01PM
|
|
Re: Zacks new analyst research update price increase and buy rating
|
6
|
Resverlogix Corp.
|
Jan 19, 2016 09:11PM
|
|
Cost of Dilution/Public Offering v Private Placement
|
6
|
Resverlogix Corp.
|
Oct 08, 2020 01:02AM
|
